HOLKIRA Trademark

Trademark Overview

On Thursday, August 15, 2013, a trademark application was filed for HOLKIRA with the United States Patent and Trademark Office. The USPTO has given the HOLKIRA trademark a serial number of 86039520. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 17, 2017. This trademark is owned by AbbVie Inc.. The HOLKIRA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of Hepatitis C
holkira

General Information

Serial Number86039520
Word MarkHOLKIRA
Filing DateThursday, August 15, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 17, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 14, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of Hepatitis C

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 23, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAbbVie Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNorth Chicago, IL 60064
Party NameAbbVie Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNorth Chicago, IL 60064

Trademark Events

Event DateEvent Description
Monday, April 17, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, April 17, 2017ABANDONMENT - NO USE STATEMENT FILED
Tuesday, September 13, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 12, 2016EXTENSION 5 GRANTED
Thursday, September 8, 2016EXTENSION 5 FILED
Thursday, September 8, 2016TEAS EXTENSION RECEIVED
Tuesday, March 15, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 14, 2016EXTENSION 4 GRANTED
Wednesday, March 9, 2016EXTENSION 4 FILED
Wednesday, March 9, 2016TEAS EXTENSION RECEIVED
Tuesday, September 15, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 14, 2015EXTENSION 3 GRANTED
Thursday, September 10, 2015EXTENSION 3 FILED
Thursday, September 10, 2015TEAS EXTENSION RECEIVED
Friday, March 27, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 26, 2015EXTENSION 2 GRANTED
Wednesday, February 11, 2015EXTENSION 2 FILED
Wednesday, March 25, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, February 11, 2015TEAS EXTENSION RECEIVED
Thursday, September 11, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 9, 2014EXTENSION 1 GRANTED
Tuesday, September 9, 2014EXTENSION 1 FILED
Tuesday, September 9, 2014TEAS EXTENSION RECEIVED
Tuesday, March 11, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 14, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 14, 2014PUBLISHED FOR OPPOSITION
Wednesday, December 25, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, December 5, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, December 2, 2013ASSIGNED TO EXAMINER
Friday, August 23, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, August 19, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

holkira hepatitis treatment preparations pharmaceutical